Lancashire and South Cumbria
Formulary
Formulary
6 Endocrine system
06-01-04 Treatment of hypoglycaemia
| Glucagon GlucaGen® HypoKit |
|
Formulary
|
| Injection 1mg vial with prefilled syringe containing water for injection |
|
| Glucagon refill pen Ogluo |
|
Formulary
|
Prescribing of Ogluo devices should be reserved for patients for whom the preparation and administration of conventional glucagon kits presents a barrier to effective treatment of hypoglycaemia and a risk to patient welfare. |
 LSCMMG: Glucagon NMR |
|
| Glucose Glucotabs® |
|
Formulary
|
Tablets 4g Consider OTC purchase |
|
LSCMMG: Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy |
|
|
Links
Diabetes UK: Diabetes when you’re unwell- LSCMMG: Diabetes: Recommended meters, strips and devices
LSCMMG: GLP-1 patient contract- LSCMMG: Glucagon NMR
- LSCMMG: Guidelines for the Home Monitoring of Blood Glucose Levels
- LSCMMG: Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy
- LSCMMG: Policy for Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus
- LSCMMG: Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus
- LSCMMG: Trans Female Gender Dysphoria Information Sheet
- LSCMMG: Trans Male Gender Dysphoria Information Sheet
- LSCMMG:Guideline for antihyperglycaemic therapy in adults with type 2 diabetes
- MHRA: Diabetes and driving
- NICE NG17: Type 1 diabetes in adults: diagnosis and management
- NICE NG18: Diabetes (type 1 and type 2) in children and young people: diagnosis and management
- NICE NG19: Diabetic foot problems: prevention and management
- NICE NG28: Type 2 diabetes in adults: management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period